Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234 Recall
Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234
FDA recall Class II
Ongoing
FDA lists this Class II recall for Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-3249-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Aug 7, 2026
- FDA report date
- Sep 30, 2026
- Quantity in commerce
- 219 units
- Distribution
- See key details
- FDA cause
- Software Design Change
What is being recalled?
Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234
Affected model & UDI checker
Search the exact identifiers published for Z-3249-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 795234 | Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234 | Check source notice | Not specified |
FDA code information
All Philips EPIQ Elite Ultrasound Systems running software version 14.0, UDI(s): (01)00884838102514 (01)00884838107540 (01)00884838114159 (01)00884838124912 (01)00884838128125
Why was this product recalled?
Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Philips Ultrasound, LLC take?
On August 7, 2026, Philips issued a Urgent Medical Device Correction Notification to affected consignees. Philips requested consignees take the following actions: 1. Due to possibility of a weak PW Doppler Signal on EPIQ Elite running 14.0 SW, customers are advised not to use C5-1 Abd Vasc Tissue Specific Preset (TSP). Please use a different TSP (e.g., Abd Gen, Abd Renal) within C5-1. Please note that this issue (i.e., Weak PW Doppler signal) is restricted to the Abd Vasc TSP with C5-1 on EPIQ Elite running SW 14.0 only. 2. Otherwise, you may continue to use your device in accordance with the IFU. 3.Circulate this notice to all users of the device so that they are aware of the product issue and associated hazard / harm. 4. Post this notice near the affected unit(s) for ease of reference 5. Please return the completed response form at the end of this notice, indicating that information on this issue has been read and understood. Philips asks that you return the completed response form no later than 30 days from receipt of this letter.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Philips Ultrasound, LLC | 510(k) clearance | May 27, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | May 27, 2026 | FDA |
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-3249-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology

